Position in BIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,677,377
+$22,868,593 QoQ
Shares Held
97,670
+368.7% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 397 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $3,522,064,706 across 101 Medical Devices names. BIO ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
15,177,317 | $1,377,189,742 | |
| 2 | SYK |
Stryker Corp
|
2,407,680 | $758,033,968 | |
| 3 | MDT |
Medtronic plc
|
7,904,930 | $618,402,670 | |
| 4 | BSX |
Boston Scientific Corp
|
3,051,613 | $130,242,842 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,041,675 | $94,229,919 | |
| 6 | GMED |
Globus Medical Inc
|
996,617 | $78,742,707 | |
| 7 | DXCM |
Dexcom Inc
|
1,011,869 | $68,149,375 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
879,516 | $56,297,816 |
All Filings in BIO
Export CSV
50 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 BIO-B | $50,403 | 170 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $28,626,974 | 97,500 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 BIO-B | $47,302 | 170 | Shares | Defined | 2026-05-11 | |
| 2026-03-31 | $5,761,482 | 20,669 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 BIO-B | — | 170 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $5,483,207 | 18,097 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 BIO-B | — | 170 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $4,927,852 | 17,575 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 BIO-B | — | 170 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $4,573,977 | 18,954 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 BIO-B | $41,138 | 170 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $5,753,615 | 23,623 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 BIO-B | $55,352 | 170 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $13,251,764 | 40,339 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 BIO-B | — | 170 | Shares | Defined | 2024-11-13 | |
| 2024-09-30 | $14,308,312 | 42,765 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 BIO-B | — | 170 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $12,021,480 | 44,017 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 BIO-B | — | 170 | Shares | Defined | 2024-05-10 | |
| 2024-03-31 | $14,553,170 | 42,077 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 BIO-B | — | 170 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $11,578,510 | 35,859 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 BIO-B | $60,360 | 170 | Shares | Defined | 2023-11-13 | |
| 2023-09-30 | $14,677,091 | 40,946 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 BIO-B | — | 170 | Shares | Defined | 2023-08-15 | |
| 2023-06-30 | $11,008,126 | 29,036 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 BIO-B | — | 56 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $14,155,996 | 29,552 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 BIO-B | — | 56 | Shares | Defined | 2023-02-13 | |
| 2022-12-31 | $10,536,636 | 25,058 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 BIO-B | — | 56 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $10,021,786 | 24,025 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 BIO-B | — | 56 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $12,393,810 | 25,038 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 BIO-B | $32,903 | 56 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $31,943,587 | 56,715 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 BIO-B | — | 56 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $38,846,118 | 51,413 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 BIO-B | $42,554 | 56 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $267,161,989 | 358,150 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 BIO-B | $35,840 | 56 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $222,385,710 | 345,164 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 BIO-B | — | 56 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $200,327,022 | 350,731 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 BIO-B | $32,152 | 56 | Shares | Defined | 2021-02-09 | |
| 2020-12-31 | $198,187,938 | 339,980 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 BIO-B | — | 56 | Shares | Defined | 2020-11-05 | |
| 2020-09-30 | $213,439,611 | 414,076 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 BIO-B | $24,470 | 56 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $238,832,337 | 528,987 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||